Cargando…

Progressive edematous lesions in subacute phase after neuroendovascular therapy

BACKGROUND: The appearance of edematous lesions in the subacute phase is a rare complication following neuroendovascular therapy. Effective management of these lesions remains unclear. In this report, a case with progressive edematous lesions in the subacute phase after neuroendovascular therapy was...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuribara, Tomoyoshi, Haraguchi, Koichi, Ohtaki, Shunya, Shimizu, Tadakazu, Matsuura, Nobuki, Ogane, Kazumi, Maruo, Yasunori, Yokoyama, Noriyuki, Mikami, Takeshi, Itou, Takeo, Mikuni, Nobuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122285/
https://www.ncbi.nlm.nih.gov/pubmed/30210906
http://dx.doi.org/10.4103/sni.sni_152_18
_version_ 1783352624206053376
author Kuribara, Tomoyoshi
Haraguchi, Koichi
Ohtaki, Shunya
Shimizu, Tadakazu
Matsuura, Nobuki
Ogane, Kazumi
Maruo, Yasunori
Yokoyama, Noriyuki
Mikami, Takeshi
Itou, Takeo
Mikuni, Nobuhiro
author_facet Kuribara, Tomoyoshi
Haraguchi, Koichi
Ohtaki, Shunya
Shimizu, Tadakazu
Matsuura, Nobuki
Ogane, Kazumi
Maruo, Yasunori
Yokoyama, Noriyuki
Mikami, Takeshi
Itou, Takeo
Mikuni, Nobuhiro
author_sort Kuribara, Tomoyoshi
collection PubMed
description BACKGROUND: The appearance of edematous lesions in the subacute phase is a rare complication following neuroendovascular therapy. Effective management of these lesions remains unclear. In this report, a case with progressive edematous lesions in the subacute phase after neuroendovascular therapy was described, and the clinical features and therapeutic strategies were discussed. CASE DESCRIPTION: A 54-year-old female with a large, right cavernous internal carotid artery aneurysm was treated with a flow diverter. Left hemiparesis developed 15 days after the procedure, and multiple edematous lesions in areas of prior catheter procedures were revealed on radiological findings. Steroid pulse therapy was employed, and the lesions were gradually reduced without any additional neurological deficits. No recurrence was recognized in the follow-up study. CONCLUSION: In some reports, pathological findings indicate that these lesions result from the presence of foreign bodies, and emboli could be caused by cotton fibers or hydrophilic polymers used as surface coatings on endovascular catheters. In this case, the edematous lesions were most likely caused by hydrophilic polymer emboli. Steroid pulse therapy had a beneficial effect on the lesions. It is important to effectively manage prescribed periods after the procedure to avoid such a rare complication.
format Online
Article
Text
id pubmed-6122285
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-61222852018-09-12 Progressive edematous lesions in subacute phase after neuroendovascular therapy Kuribara, Tomoyoshi Haraguchi, Koichi Ohtaki, Shunya Shimizu, Tadakazu Matsuura, Nobuki Ogane, Kazumi Maruo, Yasunori Yokoyama, Noriyuki Mikami, Takeshi Itou, Takeo Mikuni, Nobuhiro Surg Neurol Int Neurovascular: Case Report BACKGROUND: The appearance of edematous lesions in the subacute phase is a rare complication following neuroendovascular therapy. Effective management of these lesions remains unclear. In this report, a case with progressive edematous lesions in the subacute phase after neuroendovascular therapy was described, and the clinical features and therapeutic strategies were discussed. CASE DESCRIPTION: A 54-year-old female with a large, right cavernous internal carotid artery aneurysm was treated with a flow diverter. Left hemiparesis developed 15 days after the procedure, and multiple edematous lesions in areas of prior catheter procedures were revealed on radiological findings. Steroid pulse therapy was employed, and the lesions were gradually reduced without any additional neurological deficits. No recurrence was recognized in the follow-up study. CONCLUSION: In some reports, pathological findings indicate that these lesions result from the presence of foreign bodies, and emboli could be caused by cotton fibers or hydrophilic polymers used as surface coatings on endovascular catheters. In this case, the edematous lesions were most likely caused by hydrophilic polymer emboli. Steroid pulse therapy had a beneficial effect on the lesions. It is important to effectively manage prescribed periods after the procedure to avoid such a rare complication. Medknow Publications & Media Pvt Ltd 2018-08-28 /pmc/articles/PMC6122285/ /pubmed/30210906 http://dx.doi.org/10.4103/sni.sni_152_18 Text en Copyright: © 2018 Surgical Neurology International http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Neurovascular: Case Report
Kuribara, Tomoyoshi
Haraguchi, Koichi
Ohtaki, Shunya
Shimizu, Tadakazu
Matsuura, Nobuki
Ogane, Kazumi
Maruo, Yasunori
Yokoyama, Noriyuki
Mikami, Takeshi
Itou, Takeo
Mikuni, Nobuhiro
Progressive edematous lesions in subacute phase after neuroendovascular therapy
title Progressive edematous lesions in subacute phase after neuroendovascular therapy
title_full Progressive edematous lesions in subacute phase after neuroendovascular therapy
title_fullStr Progressive edematous lesions in subacute phase after neuroendovascular therapy
title_full_unstemmed Progressive edematous lesions in subacute phase after neuroendovascular therapy
title_short Progressive edematous lesions in subacute phase after neuroendovascular therapy
title_sort progressive edematous lesions in subacute phase after neuroendovascular therapy
topic Neurovascular: Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122285/
https://www.ncbi.nlm.nih.gov/pubmed/30210906
http://dx.doi.org/10.4103/sni.sni_152_18
work_keys_str_mv AT kuribaratomoyoshi progressiveedematouslesionsinsubacutephaseafterneuroendovasculartherapy
AT haraguchikoichi progressiveedematouslesionsinsubacutephaseafterneuroendovasculartherapy
AT ohtakishunya progressiveedematouslesionsinsubacutephaseafterneuroendovasculartherapy
AT shimizutadakazu progressiveedematouslesionsinsubacutephaseafterneuroendovasculartherapy
AT matsuuranobuki progressiveedematouslesionsinsubacutephaseafterneuroendovasculartherapy
AT oganekazumi progressiveedematouslesionsinsubacutephaseafterneuroendovasculartherapy
AT maruoyasunori progressiveedematouslesionsinsubacutephaseafterneuroendovasculartherapy
AT yokoyamanoriyuki progressiveedematouslesionsinsubacutephaseafterneuroendovasculartherapy
AT mikamitakeshi progressiveedematouslesionsinsubacutephaseafterneuroendovasculartherapy
AT itoutakeo progressiveedematouslesionsinsubacutephaseafterneuroendovasculartherapy
AT mikuninobuhiro progressiveedematouslesionsinsubacutephaseafterneuroendovasculartherapy